Metabolic Syndrome Market
1 Study Coverage
1.1 Metabolic Syndrome Revenue in Metabolic Syndrome Business (2017-2022) & (US$ Million) Introduction
1.2 Global Metabolic Syndrome Outlook 2017 VS 2022 VS 2028
1.2.1 Global Metabolic Syndrome Market Size for the Year 2017-2028
1.2.2 Global Metabolic Syndrome Market Size for the Year 2017-2028
1.3 Metabolic Syndrome Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Metabolic Syndrome in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Metabolic Syndrome Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Metabolic Syndrome Market Dynamics
1.4.1 Metabolic Syndrome Industry Trends
1.4.2 Metabolic Syndrome Market Drivers
1.4.3 Metabolic Syndrome Market Challenges
1.4.4 Metabolic Syndrome Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Metabolic Syndrome by Type
2.1 Metabolic Syndrome Market Segment by Type
2.1.1 Diabetes
2.1.2 Obesity
2.1.3 Hypercholesterolemia
2.1.4 Lysosomal storage diseases
2.2 Global Metabolic Syndrome Market Size by Type (2017, 2022 & 2028)
2.3 Global Metabolic Syndrome Market Size by Type (2017-2028)
2.4 United States Metabolic Syndrome Market Size by Type (2017, 2022 & 2028)
2.5 United States Metabolic Syndrome Market Size by Type (2017-2028)
3 Metabolic Syndrome by Application
3.1 Metabolic Syndrome Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Metabolic Syndrome Market Size by Application (2017, 2022 & 2028)
3.3 Global Metabolic Syndrome Market Size by Application (2017-2028)
3.4 United States Metabolic Syndrome Market Size by Application (2017, 2022 & 2028)
3.5 United States Metabolic Syndrome Market Size by Application (2017-2028)
4 Global Metabolic Syndrome Competitor Landscape by Company
4.1 Global Metabolic Syndrome Market Size by Company
4.1.1 Top Global Metabolic Syndrome Companies Ranked by Revenue (2021)
4.1.2 Global Metabolic Syndrome Revenue by Player (2017-2022)
4.2 Global Metabolic Syndrome Concentration Ratio (CR)
4.2.1 Metabolic Syndrome Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Metabolic Syndrome in 2021
4.2.3 Global Metabolic Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Metabolic Syndrome Headquarters, Revenue in Metabolic Syndrome Business (2017-2022) & (US$ Million) Type
4.3.1 Global Metabolic Syndrome Headquarters and Area Served
4.3.2 Global Metabolic Syndrome Companies Revenue in Metabolic Syndrome Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Metabolic Syndrome Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Metabolic Syndrome Market Size by Company
4.5.1 Top Metabolic Syndrome Players in United States, Ranked by Revenue (2021)
4.5.2 United States Metabolic Syndrome Revenue by Players (2020, 2021 & 2022)
5 Global Metabolic Syndrome Market Size by Region
5.1 Global Metabolic Syndrome Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Metabolic Syndrome Market Size by Region (2017-2028)
5.2.1 Global Metabolic Syndrome Market Size by Region: 2017-2022
5.2.2 Global Metabolic Syndrome Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Metabolic Syndrome Market Size YoY Growth 2017-2028
6.1.2 North America Metabolic Syndrome Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Metabolic Syndrome Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Metabolic Syndrome Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Metabolic Syndrome Market Size YoY Growth 2017-2028
6.3.2 Europe Metabolic Syndrome Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Metabolic Syndrome Market Size YoY Growth 2017-2028
6.4.2 Latin America Metabolic Syndrome Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Metabolic Syndrome Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Metabolic Syndrome Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Company Details
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Metabolic Syndrome Introduction
7.1.4 Novo Nordisk Revenue in Metabolic Syndrome Business (2017-2022)
7.1.5 Novo Nordisk Recent Development
7.2 Sanofi
7.2.1 Sanofi Company Details
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Metabolic Syndrome Introduction
7.2.4 Sanofi Revenue in Metabolic Syndrome Business (2017-2022)
7.2.5 Sanofi Recent Development
7.3 Merck
7.3.1 Merck Company Details
7.3.2 Merck Business Overview
7.3.3 Merck Metabolic Syndrome Introduction
7.3.4 Merck Revenue in Metabolic Syndrome Business (2017-2022)
7.3.5 Merck Recent Development
7.4 AstraZeneca
7.4.1 AstraZeneca Company Details
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Metabolic Syndrome Introduction
7.4.4 AstraZeneca Revenue in Metabolic Syndrome Business (2017-2022)
7.4.5 AstraZeneca Recent Development
7.5 Eli Lily
7.5.1 Eli Lily Company Details
7.5.2 Eli Lily Business Overview
7.5.3 Eli Lily Metabolic Syndrome Introduction
7.5.4 Eli Lily Revenue in Metabolic Syndrome Business (2017-2022)
7.5.5 Eli Lily Recent Development
7.6 AbbVie
7.6.1 AbbVie Company Details
7.6.2 AbbVie Business Overview
7.6.3 AbbVie Metabolic Syndrome Introduction
7.6.4 AbbVie Revenue in Metabolic Syndrome Business (2017-2022)
7.6.5 AbbVie Recent Development
7.7 Actelion Pharmaceuticals
7.7.1 Actelion Pharmaceuticals Company Details
7.7.2 Actelion Pharmaceuticals Business Overview
7.7.3 Actelion Pharmaceuticals Metabolic Syndrome Introduction
7.7.4 Actelion Pharmaceuticals Revenue in Metabolic Syndrome Business (2017-2022)
7.7.5 Actelion Pharmaceuticals Recent Development
7.8 Adocia
7.8.1 Adocia Company Details
7.8.2 Adocia Business Overview
7.8.3 Adocia Metabolic Syndrome Introduction
7.8.4 Adocia Revenue in Metabolic Syndrome Business (2017-2022)
7.8.5 Adocia Recent Development
7.9 Aegerion Pharmaceuticals
7.9.1 Aegerion Pharmaceuticals Company Details
7.9.2 Aegerion Pharmaceuticals Business Overview
7.9.3 Aegerion Pharmaceuticals Metabolic Syndrome Introduction
7.9.4 Aegerion Pharmaceuticals Revenue in Metabolic Syndrome Business (2017-2022)
7.9.5 Aegerion Pharmaceuticals Recent Development
7.10 Akros Pharma
7.10.1 Akros Pharma Company Details
7.10.2 Akros Pharma Business Overview
7.10.3 Akros Pharma Metabolic Syndrome Introduction
7.10.4 Akros Pharma Revenue in Metabolic Syndrome Business (2017-2022)
7.10.5 Akros Pharma Recent Development
7.11 Alnylam Pharmaceuticals
7.11.1 Alnylam Pharmaceuticals Company Details
7.11.2 Alnylam Pharmaceuticals Business Overview
7.11.3 Alnylam Pharmaceuticals Metabolic Syndrome Introduction
7.11.4 Alnylam Pharmaceuticals Revenue in Metabolic Syndrome Business (2017-2022)
7.11.5 Alnylam Pharmaceuticals Recent Development
7.12 Amarin
7.12.1 Amarin Company Details
7.12.2 Amarin Business Overview
7.12.3 Amarin Metabolic Syndrome Introduction
7.12.4 Amarin Revenue in Metabolic Syndrome Business (2017-2022)
7.12.5 Amarin Recent Development
7.13 nAmgen
7.13.1 nAmgen Company Details
7.13.2 nAmgen Business Overview
7.13.3 nAmgen Metabolic Syndrome Introduction
7.13.4 nAmgen Revenue in Metabolic Syndrome Business (2017-2022)
7.13.5 nAmgen Recent Development
7.14 Amicus Therapeutics
7.14.1 Amicus Therapeutics Company Details
7.14.2 Amicus Therapeutics Business Overview
7.14.3 Amicus Therapeutics Metabolic Syndrome Introduction
7.14.4 Amicus Therapeutics Revenue in Metabolic Syndrome Business (2017-2022)
7.14.5 Amicus Therapeutics Recent Development
7.15 Arbutus Biopharma
7.15.1 Arbutus Biopharma Company Details
7.15.2 Arbutus Biopharma Business Overview
7.15.3 Arbutus Biopharma Metabolic Syndrome Introduction
7.15.4 Arbutus Biopharma Revenue in Metabolic Syndrome Business (2017-2022)
7.15.5 Arbutus Biopharma Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Metabolic Syndrome Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Metabolic Syndrome Market Trends
Table 3. Metabolic Syndrome Market Drivers
Table 4. Metabolic Syndrome Market Challenges
Table 5. Metabolic Syndrome Market Restraints
Table 6. Global Metabolic Syndrome Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Metabolic Syndrome Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Metabolic Syndrome Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Metabolic Syndrome Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Metabolic Syndrome Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Metabolic Syndrome Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Metabolic Syndrome Revenue Share by Player, 2017-2022
Table 13. Global Metabolic Syndrome Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Metabolic Syndrome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Syndrome as of 2021)
Table 15. Top Players of Metabolic Syndrome in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Metabolic Syndrome Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Metabolic Syndrome Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Metabolic Syndrome Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Metabolic Syndrome Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Metabolic Syndrome Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Metabolic Syndrome Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Metabolic Syndrome Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Metabolic Syndrome Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Metabolic Syndrome Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Metabolic Syndrome Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Metabolic Syndrome Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Metabolic Syndrome Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Metabolic Syndrome Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Novo Nordisk Company Details
Table 31. Novo Nordisk Business Overview
Table 32. Novo Nordisk Metabolic Syndrome Product
Table 33. Novo Nordisk Revenue in Metabolic Syndrome Business (2017-2022) & (US$ Million)
Table 34. Novo Nordisk Recent Development
Table 35. Sanofi Company Details
Table 36. Sanofi Business Overview
Table 37. Sanofi Metabolic Syndrome Product
Table 38. Sanofi Revenue in Metabolic Syndrome Business (2017-2022) & (US$ Million)
Table 39. Sanofi Recent Development
Table 40. Merck Company Details
Table 41. Merck Business Overview
Table 42. Merck Metabolic Syndrome Product
Table 43. Merck Revenue in Metabolic Syndrome Business (2017-2022) & (US$ Million)
Table 44. Merck Recent Development
Table 45. AstraZeneca Company Details
Table 46. AstraZeneca Business Overview
Table 47. AstraZeneca Metabolic Syndrome Product
Table 48. AstraZeneca Revenue in Metabolic Syndrome Business (2017-2022) & (US$ Million)
Table 49. AstraZeneca Recent Development
Table 50. Eli Lily Company Details
Table 51. Eli Lily Business Overview
Table 52. Eli Lily Metabolic Syndrome Product
Table 53. Eli Lily Revenue in Metabolic Syndrome Business (2017-2022) & (US$ Million)
Table 54. Eli Lily Recent Development
Table 55. AbbVie Company Details
Table 56. AbbVie Business Overview
Table 57. AbbVie Metabolic Syndrome Product
Table 58. AbbVie Revenue in Metabolic Syndrome Business (2017-2022) & (US$ Million)
Table 59. AbbVie Recent Development
Table 60. Actelion Pharmaceuticals Company Details
Table 61. Actelion Pharmaceuticals Business Overview
Table 62. Actelion Pharmaceuticals Metabolic Syndrome Product
Table 63. Actelion Pharmaceuticals Revenue in Metabolic Syndrome Business (2017-2022) & (US$ Million)
Table 64. Actelion Pharmaceuticals Recent Development
Table 65. Adocia Company Details
Table 66. Adocia Business Overview
Table 67. Adocia Metabolic Syndrome Product
Table 68. Adocia Revenue in Metabolic Syndrome Business (2017-2022) & (US$ Million)
Table 69. Adocia Recent Development
Table 70. Aegerion Pharmaceuticals Company Details
Table 71. Aegerion Pharmaceuticals Business Overview
Table 72. Aegerion Pharmaceuticals Metabolic Syndrome Product
Table 73. Aegerion Pharmaceuticals Revenue in Metabolic Syndrome Business (2017-2022) & (US$ Million)
Table 74. Aegerion Pharmaceuticals Recent Development
Table 75. Akros Pharma Company Details
Table 76. Akros Pharma Business Overview
Table 77. Akros Pharma Metabolic Syndrome Product
Table 78. Akros Pharma Revenue in Metabolic Syndrome Business (2017-2022) & (US$ Million)
Table 79. Akros Pharma Recent Development
Table 80. Alnylam Pharmaceuticals Company Details
Table 81. Alnylam Pharmaceuticals Business Overview
Table 82. Alnylam Pharmaceuticals Metabolic Syndrome Product
Table 83. Alnylam Pharmaceuticals Revenue in Metabolic Syndrome Business (2017-2022) & (US$ Million)
Table 84. Alnylam Pharmaceuticals Recent Development
Table 85. Amarin Company Details
Table 86. Amarin Business Overview
Table 87. Amarin Metabolic Syndrome Product
Table 88. Amarin Revenue in Metabolic Syndrome Business (2017-2022) & (US$ Million)
Table 89. Amarin Recent Development
Table 90. nAmgen Company Details
Table 91. nAmgen Business Overview
Table 92. nAmgen Metabolic Syndrome Product
Table 93. nAmgen Revenue in Metabolic Syndrome Business (2017-2022) & (US$ Million)
Table 94. nAmgen Recent Development
Table 95. Amicus Therapeutics Company Details
Table 96. Amicus Therapeutics Business Overview
Table 97. Amicus Therapeutics Metabolic Syndrome Product
Table 98. Amicus Therapeutics Revenue in Metabolic Syndrome Business (2017-2022) & (US$ Million)
Table 99. Amicus Therapeutics Recent Development
Table 100. Arbutus Biopharma Company Details
Table 101. Arbutus Biopharma Business Overview
Table 102. Arbutus Biopharma Metabolic Syndrome Product
Table 103. Arbutus Biopharma Revenue in Metabolic Syndrome Business (2017-2022) & (US$ Million)
Table 104. Arbutus Biopharma Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Metabolic Syndrome Product Picture
Figure 2. Global Metabolic Syndrome Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Metabolic Syndrome Market Size 2017-2028 (US$ Million)
Figure 4. United States Metabolic Syndrome Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Metabolic Syndrome Market Size 2017-2028 (US$ Million)
Figure 6. United States Metabolic Syndrome Market Share in Global 2017-2028
Figure 7. Metabolic Syndrome Report Years Considered
Figure 8. Product Picture of Diabetes
Figure 9. Product Picture of Obesity
Figure 10. Product Picture of Hypercholesterolemia
Figure 11. Product Picture of Lysosomal storage diseases
Figure 12. Global Metabolic Syndrome Market Share by Type in 2022 & 2028
Figure 13. Global Metabolic Syndrome Market Size by Type (2017-2028) & (US$ Million)
Figure 14. Global Metabolic Syndrome Market Share by Type (2017-2028)
Figure 15. United States Metabolic Syndrome Market Share by Type in 2022 & 2028
Figure 16. United States Metabolic Syndrome Market Size by Type (2017-2028) & (US$ Million)
Figure 17. United States Metabolic Syndrome Market Share by Type (2017-2028)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Clinic
Figure 20. Product Picture of Others
Figure 21. Global Metabolic Syndrome Market Share by Application in 2022 & 2028
Figure 22. Global Metabolic Syndrome Market Size by Application (2017-2028) & (US$ Million)
Figure 23. Global Metabolic Syndrome Market Share by Application (2017-2028)
Figure 24. United States Metabolic Syndrome Market Share by Application in 2022 & 2028
Figure 25. United States Metabolic Syndrome Market Size by Application (2017-2028) & (US$ Million)
Figure 26. United States Metabolic Syndrome Market Share by Application (2017-2028)
Figure 27. North America Metabolic Syndrome Market Size Growth Rate 2017-2028 (US$ Million)
Figure 28. U.S. Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Canada Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Europe Metabolic Syndrome Market Size Growth Rate 2017-2028 (US$ Million)
Figure 31. Germany Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. France Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. U.K. Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Italy Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Russia Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Metabolic Syndrome Market Size Growth Rate 2017-2028 (US$ Million)
Figure 37. China Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Japan Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. South Korea Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. India Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Australia Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Taiwan Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Indonesia Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Thailand Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Malaysia Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Philippines Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Latin America Metabolic Syndrome Market Size Growth Rate 2017-2028 (US$ Million)
Figure 48. Mexico Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Brazil Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Argentina Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Metabolic Syndrome Market Size Growth Rate 2017-2028 (US$ Million)
Figure 52. Turkey Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. U.A.E Metabolic Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Novo Nordisk Revenue Growth Rate in Metabolic Syndrome Business (2017-2022)
Figure 56. Sanofi Revenue Growth Rate in Metabolic Syndrome Business (2017-2022)
Figure 57. Merck Revenue Growth Rate in Metabolic Syndrome Business (2017-2022)
Figure 58. AstraZeneca Revenue Growth Rate in Metabolic Syndrome Business (2017-2022)
Figure 59. Eli Lily Revenue Growth Rate in Metabolic Syndrome Business (2017-2022)
Figure 60. AbbVie Revenue Growth Rate in Metabolic Syndrome Business (2017-2022)
Figure 61. Actelion Pharmaceuticals Revenue Growth Rate in Metabolic Syndrome Business (2017-2022)
Figure 62. Adocia Revenue Growth Rate in Metabolic Syndrome Business (2017-2022)
Figure 63. Aegerion Pharmaceuticals Revenue Growth Rate in Metabolic Syndrome Business (2017-2022)
Figure 64. Akros Pharma Revenue Growth Rate in Metabolic Syndrome Business (2017-2022)
Figure 65. Alnylam Pharmaceuticals Revenue Growth Rate in Metabolic Syndrome Business (2017-2022)
Figure 66. Amarin Revenue Growth Rate in Metabolic Syndrome Business (2017-2022)
Figure 67. nAmgen Revenue Growth Rate in Metabolic Syndrome Business (2017-2022)
Figure 68. Amicus Therapeutics Revenue Growth Rate in Metabolic Syndrome Business (2017-2022)
Figure 69. Arbutus Biopharma Revenue Growth Rate in Metabolic Syndrome Business (2017-2022)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Industry Market Size
